Vicor CFO exercises options, sells 2,124 shares
VICOR CORP CFO James F. Schmidt reported an exercise-and-sell transaction in company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VICOR CORP CFO James F. Schmidt reported an exercise-and-sell transaction in company stock. He exercised options to acquire 2,124 shares of common stock at strike prices of $32.89 and $44.07 per share, then sold the same 2,124 shares in multiple open-market trades under a Rule 10b5-1 trading plan at prices between $351.38 and $367.12 per share. Following these transactions, he holds no common shares directly but was granted 548 non‑qualified stock options with an exercise price of $365.53 per share expiring on June 22, 2036.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non Qualified Stock Option | 548 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 1,216 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 908 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,216 | $32.89 | $40K |
| Exercise | Common Stock | 908 | $44.07 | $40K |
| Sale | Common Stock | 145 | $351.38 | $51K |
| Sale | Common Stock | 45 | $354.11 | $16K |
| Sale | Common Stock | 90 | $356.485 | $32K |
| Sale | Common Stock | 435 | $357.6951 | $156K |
| Sale | Common Stock | 145 | $359.84 | $52K |
| Sale | Common Stock | 280 | $360.9464 | $101K |
| Sale | Common Stock | 480 | $362.5288 | $174K |
| Sale | Common Sock | 190 | $363.9721 | $69K |
| Sale | Common Stock | 169 | $365.1195 | $62K |
| Sale | Common Stock | 145 | $367.061 | $53K |
Footnotes (12)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.3800 to $351.3800.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.1100 to $354.1100
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.3000 to $356.6700.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.5000 to $357.9700.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.5700 to $360.4400
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.5800 to $361.2000.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.1100 to $363.0900.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.7800 to $364.4800.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.0300 to $365.8000.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.9300 to $367.1200
- F12. Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on June 22, 2026 and vest over a five year period.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Non Qualified Stock Option financial
weighted average price financial
Amended and Restated 2000 Stock Option and Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vicor (VICR) CFO James F. Schmidt report?
What option exercises did the Vicor (VICR) CFO report in this Form 4?
Did the Vicor (VICR) CFO receive any new equity awards in this filing?
What are the CFO’s reported Vicor (VICR) holdings after these transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.